• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型 3-(2-氯苯基)-和 3-(3-氯苯基)-2,5-二氧代-吡咯烷-1-基-乙酰胺的合成、抗惊厥和镇痛活性。

Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides.

机构信息

Department of Medicinal Chemistry, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688 Krakow, Poland.

Department of Pharmacodynamics, Faculty of Pharmacy, Jagiellonian University Medical College, Medyczna 9 St., 30-688 Krakow, Poland.

出版信息

Molecules. 2021 Mar 12;26(6):1564. doi: 10.3390/molecules26061564.

DOI:10.3390/molecules26061564
PMID:33809109
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8000848/
Abstract

The new series of 3-(2-chlorophenyl)- and 3-(3-chlorophenyl)-pyrrolidine-2,5-dione-acetamide derivatives as potential anticonvulsant and analgesic agents was synthesized. The compounds obtained were evaluated in the following acute models of epilepsy: maximal electroshock (MES), psychomotor (6 Hz, 32 mA), and subcutaneous pentylenetetrazole (PTZ) seizure tests. The most active substance-3-(2-chlorophenyl)-1-{2-[4-(4-fluorophenyl)piperazin-1-yl]-2-oxoethyl}-pyrrolidine-2,5-dione () showed more beneficial ED and protective index values than the reference drug-valproic acid (68.30 mg/kg vs. 252.74 mg/kg in the MES test and 28.20 mg/kg vs. 130.64 mg/kg in the 6 Hz (32 mA) test, respectively). Since anticonvulsant drugs are often effective in neuropathic pain management, the antinociceptive activity for two the promising compounds-namely, and -was also investigated in the formalin model of tonic pain. Additionally, for the aforementioned compounds, the affinity for the voltage-gated sodium and calcium channels, as well as GABA and TRPV1 receptors, was determined. As a result, the most probable molecular mechanism of action for the most active compound relies on interaction with neuronal voltage-sensitive sodium (site 2) and L-type calcium channels. Compounds and were also tested for their neurotoxic and hepatotoxic properties and showed no significant cytotoxic effect.

摘要

新的 3-(2-氯苯基)-和 3-(3-氯苯基)-吡咯烷-2,5-二酮-乙酰胺衍生物系列作为潜在的抗惊厥和镇痛剂被合成。所得到的化合物在以下几种急性癫痫模型中进行了评估:最大电休克(MES)、运动(6 Hz,32 mA)和皮下戊四氮(PTZ)惊厥测试。最活跃的物质 3-(2-氯苯基)-1-{2-[4-(4-氟苯基)哌嗪-1-基]-2-氧代乙基}-吡咯烷-2,5-二酮()在 MES 测试中,其 ED 和保护指数值比参考药物丙戊酸(68.30 mg/kg 比 252.74 mg/kg)更有利,在 6 Hz(32 mA)测试中,其 ED 和保护指数值比参考药物丙戊酸(28.20 mg/kg 比 130.64 mg/kg)更有利。由于抗惊厥药物通常在神经病理性疼痛管理中有效,因此还研究了两种有前途的化合物——和——在福尔马林强直痛模型中的镇痛活性。此外,还测定了上述两种化合物对电压门控钠和钙通道以及 GABA 和 TRPV1 受体的亲和力。结果表明,最活跃的化合物的可能分子作用机制依赖于与神经元电压敏感的钠(部位 2)和 L 型钙通道的相互作用。还测试了化合物和它们的神经毒性和肝毒性,没有显示出明显的细胞毒性作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/8d0a71f3b752/molecules-26-01564-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/5f5f8da8439a/molecules-26-01564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/241b8f376d54/molecules-26-01564-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/1619d58d25a7/molecules-26-01564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/26de08ae3a1b/molecules-26-01564-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/8d0a71f3b752/molecules-26-01564-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/5f5f8da8439a/molecules-26-01564-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/241b8f376d54/molecules-26-01564-sch001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/1619d58d25a7/molecules-26-01564-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/26de08ae3a1b/molecules-26-01564-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9c66/8000848/8d0a71f3b752/molecules-26-01564-g004.jpg

相似文献

1
Synthesis, Anticonvulsant, and Antinociceptive Activity of New 3-(2-Chlorophenyl)- and 3-(3-Chlorophenyl)-2,5-dioxo-pyrrolidin-1-yl-acetamides.新型 3-(2-氯苯基)-和 3-(3-氯苯基)-2,5-二氧代-吡咯烷-1-基-乙酰胺的合成、抗惊厥和镇痛活性。
Molecules. 2021 Mar 12;26(6):1564. doi: 10.3390/molecules26061564.
2
Synthesis, Anticonvulsant and Antinociceptive Activity of New Hybrid Compounds: Derivatives of 3-(3-Methylthiophen-2-yl)-pyrrolidine-2,5-dione.合成、抗惊厥和新型杂合化合物的镇痛活性:3-(3-甲基噻吩-2-基)-吡咯烷-2,5-二酮的衍生物。
Int J Mol Sci. 2020 Aug 11;21(16):5750. doi: 10.3390/ijms21165750.
3
Anticonvulsant and antinociceptive activity of new amides derived from 3-phenyl-2,5-dioxo-pyrrolidine-1-yl-acetic acid in mice.3-苯基-2,5-二氧代吡咯烷-1-基乙酸衍生的新型酰胺在小鼠体内的抗惊厥和抗伤害作用。
Eur J Pharmacol. 2016 Jun 15;781:239-49. doi: 10.1016/j.ejphar.2016.04.033. Epub 2016 Apr 22.
4
Design, synthesis and biological activity of new amides derived from 3-methyl-3-phenyl-2,5-dioxo-pyrrolidin-1-yl-acetic acid.新型 3-甲基-3-苯基-2,5-二氧代吡咯烷-1-基乙酸衍生酰胺的设计、合成与生物活性。
Eur J Med Chem. 2015 Sep 18;102:14-25. doi: 10.1016/j.ejmech.2015.07.017. Epub 2015 Jul 13.
5
The Search for New Anticonvulsants in a Group of (2,5-Dioxopyrrolidin-1-yl)(phenyl)Acetamides with Hybrid Structure-Synthesis and In Vivo/In Vitro Studies.(2,5-二氧代吡咯烷-1-基)(苯基)乙酰胺类杂合结构化合物的新型抗惊厥药物的研究-合成及体内/体外研究。
Int J Mol Sci. 2020 Nov 20;21(22):8780. doi: 10.3390/ijms21228780.
6
Synthesis, anticonvulsant, and antinociceptive activity of new 3-(3-methyl-2,5-dioxo-3-phenylpyrrolidin-1-yl)propanamides and 3-phenyl-butanamides.新型 3-(3-甲基-2,5-二氧代-3-苯基吡咯烷-1-基)丙酰胺和 3-苯基丁酰胺的合成、抗惊厥和镇痛活性。
Arch Pharm (Weinheim). 2021 Jan;354(1):e2000225. doi: 10.1002/ardp.202000225. Epub 2020 Sep 16.
7
Design, Synthesis and Biological Activity of New Amides Derived from 3-Benzhydryl and 3-sec-Butyl-2,5-dioxo-pyrrolidin-1-yl-acetic Acid.新型酰胺的设计、合成及生物活性研究,这些酰胺是由 3-联苯甲基和 3-仲丁基-2,5-二氧代-吡咯烷-1-基-乙酸衍生而来。
ChemMedChem. 2021 May 18;16(10):1619-1630. doi: 10.1002/cmdc.202001007. Epub 2021 Mar 2.
8
Analgesic, antiallodynic, and anticonvulsant activity of novel hybrid molecules derived from N-benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide and 2-(2,5-dioxopyrrolidin-1-yl)butanamide in animal models of pain and epilepsy.新型杂合分子(源自N-苄基-2-(2,5-二氧代吡咯烷-1-基)丙酰胺和2-(2,5-二氧代吡咯烷-1-基)丁酰胺)在疼痛和癫痫动物模型中的镇痛、抗痛觉过敏及抗惊厥活性。
Naunyn Schmiedebergs Arch Pharmacol. 2017 Jun;390(6):567-579. doi: 10.1007/s00210-017-1358-3. Epub 2017 Feb 10.
9
KA-11, a Novel Pyrrolidine-2,5-dione Derived Broad-Spectrum Anticonvulsant: Its Antiepileptogenic, Antinociceptive Properties and in Vitro Characterization.KA-11,一种新型吡咯烷-2,5-二酮衍生的广谱抗惊厥药:其抗癫痫发生、镇痛特性及体外特征。
ACS Chem Neurosci. 2019 Jan 16;10(1):636-648. doi: 10.1021/acschemneuro.8b00476. Epub 2018 Oct 10.
10
Identification of New Compounds with Anticonvulsant and Antinociceptive Properties in a Group of 3-substituted (2,5-dioxo-pyrrolidin-1-yl)(phenyl)-Acetamides.一组 3-取代(2,5-二氧代-吡咯烷-1-基)(苯基)-乙酰酰胺中具有抗惊厥和抗伤害感受特性的新化合物的鉴定。
Int J Mol Sci. 2021 Dec 3;22(23):13092. doi: 10.3390/ijms222313092.

引用本文的文献

1
Discovery of Novel Isonipecotic Acid-Based Heteroaryl Amino Acid Derivatives as Potential Anticonvulsant Agents: Design, Synthesis, In-Silico ADME Study, and Molecular Docking Studies.新型基于异哌啶酸的杂芳基氨基酸衍生物作为潜在抗惊厥剂的发现:设计、合成、计算机辅助ADME研究及分子对接研究
J Pharm Bioallied Sci. 2023 Oct-Dec;15(4):205-211. doi: 10.4103/jpbs.jpbs_478_23. Epub 2023 Dec 11.
2
Identification of New Antiseizure Medication Candidates in Preclinical Animal Studies.在临床前动物研究中鉴定新型抗癫痫药物候选物。
Int J Mol Sci. 2023 Aug 24;24(17):13143. doi: 10.3390/ijms241713143.
3
Microbiota-Gut-Brain Axis and Epilepsy: A Review on Mechanisms and Potential Therapeutics.

本文引用的文献

1
Anti-inflammatory and antinociceptive effects of the isatin derivative (Z)-2-(5-chloro-2-oxoindolin-3-ylidene)-N-phenyl-hydrazinecarbothioamide in mice.(Z)-2-(5-氯-2-氧代吲哚啉-3-亚基)-N-苯基-肼甲硫酰胺在小鼠体内的抗炎和镇痛作用。
Braz J Med Biol Res. 2020;53(10):e10204. doi: 10.1590/1414-431X202010204. Epub 2020 Sep 7.
2
Antipyretic, anti-inflammatory and analgesic activities of Periplaneta americana extract and underlying mechanisms.美洲大蠊提取物的解热、抗炎和镇痛作用及其作用机制。
Biomed Pharmacother. 2020 Mar;123:109753. doi: 10.1016/j.biopha.2019.109753. Epub 2019 Dec 19.
3
The current approach of the Epilepsy Therapy Screening Program contract site for identifying improved therapies for the treatment of pharmacoresistant seizures in epilepsy.
微生物群-肠道-脑轴与癫痫:机制与潜在治疗策略的综述。
Front Immunol. 2021 Oct 11;12:742449. doi: 10.3389/fimmu.2021.742449. eCollection 2021.
癫痫治疗筛选计划合同网站当前的方法是为识别改善治疗药物难治性癫痫发作的治疗方法。
Neuropharmacology. 2020 Apr;166:107811. doi: 10.1016/j.neuropharm.2019.107811. Epub 2019 Nov 30.
4
Pregabalin for neuropathic pain in adults.普瑞巴林用于治疗成人神经性疼痛。
Cochrane Database Syst Rev. 2019 Jan 23;1(1):CD007076. doi: 10.1002/14651858.CD007076.pub3.
5
Pharmacotherapy for Focal Seizures in Children and Adolescents.儿童和青少年局灶性癫痫的药物治疗。
Drugs. 2018 Sep;78(13):1321-1337. doi: 10.1007/s40265-018-0959-6.
6
Evaluation of anticonvulsant and analgesic activity of new hybrid compounds derived from N-phenyl-2-(2,5-dioxopyrrolidin-1-yl)-propanamides and -butanamides.对源自N-苯基-2-(2,5-二氧代吡咯烷-1-基)丙酰胺和丁酰胺的新型杂化化合物的抗惊厥和镇痛活性评估。
Epilepsy Res. 2018 Jul;143:11-19. doi: 10.1016/j.eplepsyres.2018.03.024. Epub 2018 Mar 30.
7
Treatment Outcomes in Patients With Newly Diagnosed Epilepsy Treated With Established and New Antiepileptic Drugs: A 30-Year Longitudinal Cohort Study.新诊断癫痫患者使用现有和新型抗癫痫药物治疗的治疗结局:一项长达 30 年的纵向队列研究。
JAMA Neurol. 2018 Mar 1;75(3):279-286. doi: 10.1001/jamaneurol.2017.3949.
8
Antiallodynic and antihyperalgesic activity of new 3,3-diphenyl-propionamides with anticonvulsant activity in models of pain in mice.具有抗惊厥活性的新型 3,3-二苯基丙酰胺类化合物在小鼠疼痛模型中的抗痛觉过敏和抗痛觉超敏作用。
Eur J Pharmacol. 2018 Feb 15;821:39-48. doi: 10.1016/j.ejphar.2017.12.036. Epub 2017 Dec 17.
9
Operational classification of seizure types by the International League Against Epilepsy: Position Paper of the ILAE Commission for Classification and Terminology.国际抗癫痫联盟对癫痫发作类型的操作性分类:国际抗癫痫联盟分类和术语委员会立场文件
Epilepsia. 2017 Apr;58(4):522-530. doi: 10.1111/epi.13670. Epub 2017 Mar 8.
10
Neuropathic pain.神经性疼痛。
Nat Rev Dis Primers. 2017 Feb 16;3:17002. doi: 10.1038/nrdp.2017.2.